Abstract:Leptin resistance is induced via leptin signaling blockade by chronic overstimulation of the leptin receptor and intracellular signaling defect or increased hypothalamic inflammation and suppressor of cytokine signaling (SOCS)-3 expression. High-fat diet triggers leptin resistance induced by at least two independent causes: first, the limited ability of peripheral leptin to activate hypothalamic signaling transducers and activators of transcription (STAT) signaling and secondly a signaling defect in leptin-responsive hypothalamic neurons. Central leptin resistance is dependent on decreased leptin transport efficiency across the blood brain barrier (BBB) rather than hypothalamic leptin insensitivity. Since the hypothalamic phosphorylated STAT3 (pSTAT3) represents a sensitive and specific readout of leptin receptor-B signaling, the assessment of pSTAT3 levels is the gold standard. Hypertriglyceridemia is one of important factors to inhibit the transport of leptin across BBB in obesity. Mismatch between high leptin and the amount of leptin receptor expression in obesity triggers brain leptin resistance via increasing hypothalamic inflammation and SOCS-3 expression. Therapeutic strategies that regulate the passage of leptin to the brain include the development of modifications in the structure of leptin analogues as well as the synthesis of new leptin receptor agonists with increased BBB permeability. In the hyperleptinemic state, polyethylene glycol (PEG)-modified leptin is unable to pass through the BBB. Peripheral histone deacetylase (HDAC) 6 inhibitor, tubastatin, and metformin increase central leptin sensitization. While add-on therapy with anagliptin, metformin and miglitol reduce leptin concentrations, the use of long-acting leptin analogs, and exendin-4 lead to the recovery of leptin sensitivity. Contouring surgery with fat removal, and bariatric surgery independently of the type of surgery performed provide significant improvement in leptin concentrations. Although approaches to correcting leptin resistance have shown some success, no clinically effective application has been developed to date. Due to the impairment of central and peripheral leptin signaling, as well as the extensive integration of leptin-sensitive metabolic pathways with other neurons, the effectiveness of methods used to eliminate leptin resistance is extremely limited.

History and future of leptin: Discovery, regulation and signaling

Leptin physiology and pathophysiology: knowns and unknowns 30 years after its discovery

Leptin signaling and leptin resistance.

Leptin in humans: lessons from translational research

Leptin and the endocrine control of energy balance

Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?

Leptin and Obesity: Role and Clinical Implication

The History of Obesity Research

Leptin Signalings and Leptin Resistance

A Small Contribution to a Large System: The Leptin Receptor Complex

Neuroendocrinological and Clinical Aspects of Leptin

The Leptin Resistance.

Leptin, the brain and energy homeostasis: From an apparently simple to a highly complex neuronal system

The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective

The Leptin Paradox-A Treacherous Art in Cardiac Sequelae of Obesity

Leptin and the regulation of body weight in mammals

Leptin in Normal Physiology and Leptin Resistance

Leptin revisited: its mechanism of action and potential for treating diabetes

The cellular and molecular bases of leptin and ghrelin resistance in obesity

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity